Vital Farms Q3 2026 slides: margin recovery offset by guidance cut
Vital Farms (VITL) reported Q3 2026 revenue of $182.2M, down 8.4% YoY but up 10% QoQ. Gross margin improved to 23.1% from 6.9% QoQ but fell from 37.7% YoY. Adjusted EBITDA turned positive at $1.5M. The company cut full-year guidance, citing market normalization and customer shifts to lower-priced alternatives. The stock fell 2.73% post-announcement.
How this was made
The 30-second read
Why it matters
The guidance cut is the first public disclosure of a lower revenue outlook, likely triggering sell pressure. Margin improvement may mitigate some downside but does not offset the revenue shortfall.
Market read
First‑time guidance cut for a mid‑cap consumer‑discretionary stock, creating immediate trading relevance.
What to watch
Cost reductions and positive EBITDA turn could support longer‑term margins despite short‑term guidance cut.
Background
Vital Farms, a pasture‑raised egg producer, reported Q3 2026 results showing margin recovery but a sharp guidance reduction as the egg market normalizes after avian influenza disruptions.
Ticker impact
Vital Farms cut full-year 2026 revenue guidance to $730M and adjusted EBITDA to -$15M, prompting a 2.7% share decline.
downward pressure as investors price in reduced revenue and EBITDA outlook
The new guidance is materially below prior expectations and was the first disclosure, creating immediate downside risk.
Market effects
Egg and specialty food sector may see broader pressure as peers face similar post‑influenza demand normalization.
U.S. consumer discretionary segment could see modest pullback amid lower premium‑product demand.
Limited to U.S. specialty protein niche; unlikely to affect broader market indices.
Counterpoint
If distribution expansion continues, the revenue decline may be temporary and the stock could rebound.
Key entities
- companyVital Farms
NASDAQ‑listed specialty egg producer (ticker VITL).
